Mack Anthony P. 4
4 · Virpax Pharmaceuticals, Inc. · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Mack Anthony P.
DirectorChief Executive Officer10% Owner
Transactions
- Award
Stock Option (right to buy)
[F1]2021-04-07+50,000→ 50,000 totalExercise: $4.62Exp: 2031-04-07→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests in three equal annual installments commencing on April 7, 2022.
Signature
/s/ Christopher Chipman, attorney-in-fact|2021-04-09